(Q39390874)

11 September 2017

A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia (English)

2 references

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

11 September 2017

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

2

Wiernik PH

1 reference

11 September 2017

J. A. Levi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59627

10 April 2022

language of work or name

English

0 references

publication date

1 July 1976

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

1 reference

11 September 2017

38

1 reference

11 September 2017

1

1 reference

11 September 2017

36-41

1 reference

11 September 2017

2

30

2358

Brockman

1970

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

Intermittent guanazole therapy in adult acute leukemia

10 April 2022

4

14

271

Hewlett

1972

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

Combination Chemotherapy of Adult Acute Nonlymphoblastic Leukemia

10 April 2022

7

76

397

Levi

1972

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

8

30

2760

Li

1970

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

10 April 2022

11

82

351

Schimpff

1975

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

5-Azacytidine, a new, highly effective cancerostatic

10 April 2022

series ordinal

12

volume

20

page(s)

202

0 references

Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).

13

49

505

Wiernik

1970

1 reference

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197607)38:1%3C36::AID-CNCR2820380107%3E3.0.CO;2-M

10 April 2022

Identifiers

10.1002/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M

1 reference

release_5nxwpj2y7nf3fcsewb2wpt2mb4

11 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5nxwpj2y7nf3fcsewb2wpt2mb4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference